← Leaderboards
Alexandria K. Maurer
New York University School Of Medicine
$117,828
Attributed
$117,828
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.7K · FY2013–15$50K$37.5K$25K$12.5K$0
'13
'14
'15
Funding mix
By agency
NIH$117,828 · 1
By mechanism
F30$117,828 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Ivaylo Ivanov Ivanov$11,478,220
- Mark Joseph Mulligan$87,307,980
- Dan R Littman$30,444,906
- Victor J Torres$18,227,816
- Bo Shopsin$6,212,959
Others in their field
Top investigators on “Allogenic”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$40,815,122
- Marcel R M Van Den Brink · Sloan-Kettering Institute For Cancer Res$39,678,762
- Bruce R. Blazar · University Of Minnesota$37,193,531
- Megan Sykes · Columbia University Health Sciences$33,587,479
Research focus
AllogenicAnimalsAntibioticsAntibiotic TherapyAutophagocytosisBacteriaBacteroidesBaseBloodBlood CellsBlood DonorBone MarrowCell LineageCollaborationsCommensal MicrobesComplicationControl AnimalCrohn&AposData SetDeep SequencingDegradation PathwayDisease ModelDisease OutcomeAlcaligenes
Grant awards (3)
The role of commensal bacteria in enhanced GVHD due to Atg16L1 mutation - Resubmi$39,720
F30 · FY2015 · DK · contact PI
The role of commensal bacteria in enhanced GVHD due to Atg16L1 mutation - Resubmi$39,276
F30 · FY2014 · DK · contact PI
The role of commensal bacteria in enhanced GVHD due to Atg16L1 mutation - Resubmi$38,832
F30 · FY2013 · DK · contact PI